Juan Jesús
Cruz Hernández
Publications (302) Juan Jesús Cruz Hernández publications
2024
-
Biología celular y molecular del cáncer
Oncología clínica (Arán Ediciones), pp. 13-23
-
Diagnóstico nosológico y de extensión. Factores pronósticos
Oncología clínica (Arán Ediciones), pp. 59-71
-
Epidemiología del cáncer. Factores de riesgo y carcinogénesis
Oncología clínica (Arán Ediciones), pp. 25-42
-
Indicators to evaluate quality of care in head and neck cancer in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097
-
Oncología clínica
coord.
Arán Ediciones
-
Tumores de origen desconocido
Oncología clínica (Arán Ediciones), pp. 407-418
2023
-
Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Chinese Clinical Oncology, Vol. 12, Núm. 6
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Multimodal Physical Exercise and Functional Rehabilitation Program in Oncological Patients with Cancer-Related Fatigue—A Randomized Clinical Trial
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 6
-
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 4
-
Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2
Reumatologia clinica, Vol. 19, Núm. 2, pp. 121
2022
-
Acute esophageal necrosis induced by immune checkpoint inhibitors
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183
-
Adaptation and validation of the Spanish version of the everyday cognition battery for assessing everyday cognition in older adults
BMC Geriatrics, Vol. 22, Núm. 1
-
Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 266-269
-
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
European Urology Focus, Vol. 8, Núm. 6, pp. 1673-1682
-
Epidemiological Study of Prostate Cancer in the Province of Salamanca (2006-2015)
Archivos espanoles de urologia, Vol. 75, Núm. 7, pp. 630-637
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
-
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer
Oral Oncology, Vol. 134
2021
-
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab
Reumatologia Clinica, Vol. 17, Núm. 10, pp. 559-561